Blood News and Research

RSS

Scientists develop new method to regenerate cartilage

Unlike our bones, the cartilage inside our joints is not vascularized (i.e., it has no blood vessels). This is one reason why cartilage does not heal well after an injury. In athletes in particular, joint injuries often result in cartilage degeneration and arthritis. The process is chronic and irreversible, and to this day, no effective treatment exists.

12 Oct 2013

Canadian discovery could lead to development of vaccine against Epstein-Barr virus

Development of a vaccine against Epstein-Barr virus has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system.

12 Oct 2013

Island Doctors to host community diabetes awareness campaigns across NE Florida

On October 12th and 13th, Island Doctors will participate, sponsor, and co-host three events in Putnam and St. Johns County, Florida. The events are part of Island Doctors continued commitment to community diabetes awareness campaigns across NE Florida.

12 Oct 2013

High voltage, short pulsed electric fields destroy cells in skin tissue, lead to scarless tissue regeneration

High voltage, short pulsed electric fields, used for disinfection and solid tumor destruction, selectively damage cell membranes, while preserving overall tissue structure, a phenomenon that may be a key factor in scarless tissue regeneration.

11 Oct 2013

Scientists introduce new approach to the production of synthetic heparin mimetics

One of the risks of any large operation is the occurrence of blood clots. To prevent this, patients are routinely given the anticoagulant heparin or related drugs. American scientists have now introduced a new approach to the production of synthetic heparin mimetics with better activity profiles.

11 Oct 2013

WHO, Health Care without Harm to launch Mercury-Free Healthcare by 2020

WHO and Health Care without Harm have joined forces to launch a new initiative to get mercury removed from all medical measuring devices by 2020.

11 Oct 2013

New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

Cancer immunotherapy can successfully use the body's own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical effectiveness. A new gene transfer strategy that introduces modified, immune-stimulating human stem cells is both feasible and effective for achieving persistent immunotherapy to treat leukemias and lymophomas, according to a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

11 Oct 2013

New research shows blood pressure remains major problem in China

With a recent World Health Organization (WHO) report1 showing hypertension affects over 40% of Chinese adults aged 45 or older, combating high blood pressure (BP) will be high on the agenda of the 24th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress (GW-ICC & APHC), in Beijing (10 to 13 October 2013).

11 Oct 2013

Hispanics with kidney failure are less likely to receive kidney transplant due to living location

In the United States, Hispanics with kidney failure are less likely than non-Hispanic whites to receive a kidney transplant largely due to their blood type and because of where they live, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

11 Oct 2013

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Djillali Annane, M.D., Ph.D., of Raymond Poincare Hospital, Garches, France, and colleagues conducted a study to compare the effects of 2 types of intravenous fluids on survival for critically ill patients in an intensive care unit.

11 Oct 2013

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Researchers at the University of California, San Diego School of Medicine have identified 13 metabolites - small molecules produced by cellular metabolism - that are significantly different in patients with diabetes and chronic kidney disease compared to healthy controls.

11 Oct 2013

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

For childhood cancer survivors, risk factors associated with lifestyle, particularly hypertension, dramatically increase the likelihood of developing serious heart problems as adults, according to a national study led by St. Jude Children's Research Hospital. The findings appear in the current issue of the Journal of Clinical Oncology.

11 Oct 2013

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.

11 Oct 2013

Finding highlights new ways of treating inflammation disorders

A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases.

11 Oct 2013

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

The U.S. Food and Drug Administration today approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis either before transplant, or after renal (kidney) transplantation in which there is recurrence of FSGS.

11 Oct 2013

IVF and chromosome testing: an interview with Dr. Santiago Munné

The Society for Assisted Reproductive Technology (SART) releases every year a report on pregnancy rates by maternal age. The last one shows a decline on implantation rates per embryo from 36% in young women, to 27.3% in women 35-37, 17.5% in 38-40, and less than 10% above 40 years of age.

10 Oct 2013

Teva Cutting 5,000 Jobs In Global Restructuring

...

10 Oct 2013

FDA clears Sotera Wireless' patented continuous non-invasive blood pressure technology

Sotera Wireless, Inc. today announced the U.S. Food and Drug Administration has cleared the Company's patented continuous non-invasive blood pressure technology, a new feature of the ViSi Mobile wireless patient monitoring system. For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the use of a catheter or blood pressure cuff.

10 Oct 2013

Drugs often fail to bring acromegaly under control in routine clinical practice

Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.

10 Oct 2013

Combining gene therapy with stem cells leads to faster healing of burns

Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater blood flow to the site of the wound.

10 Oct 2013

Blood News and Research

Scientists develop new method to regenerate cartilage

Canadian discovery could lead to development of vaccine against Epstein-Barr virus

Island Doctors to host community diabetes awareness campaigns across NE Florida

High voltage, short pulsed electric fields destroy cells in skin tissue, lead to scarless tissue regeneration

Scientists introduce new approach to the production of synthetic heparin mimetics

WHO, Health Care without Harm to launch Mercury-Free Healthcare by 2020

New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

New research shows blood pressure remains major problem in China

Hispanics with kidney failure are less likely to receive kidney transplant due to living location

Study compares effects of 2 intravenous fluids on survival for critically ill patients in ICU

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

Finding highlights new ways of treating inflammation disorders

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

IVF and chromosome testing: an interview with Dr. Santiago Munné

Teva Cutting 5,000 Jobs In Global Restructuring

FDA clears Sotera Wireless' patented continuous non-invasive blood pressure technology

Drugs often fail to bring acromegaly under control in routine clinical practice

Combining gene therapy with stem cells leads to faster healing of burns

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News